The Anti-Obesity Effect of the Palatinose-Based Formula Inslow is Likely due to an Increase in the Hepatic PPAR-α and Adipocyte PPAR-γ Gene Expressions

Abdominal obesity is a principal risk factor in the development of metabolic syndrome. Previously, we showed that a palatinose-based liquid formula, Inslow/MHN-01, suppressed postprandial plasma glucose level and reduced visceral fat accumulation better than the standard formula (SF). To elucidate t...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Matsuo, Kaoru, Arai, Hidekazu, Muto, Kazusa, Fukaya, Makiko, Sato, Tadatoshi, Mizuno, Akira, Sakuma, Masae, Yamanaka-Okumura, Hisami, Sasaki, Hajime, Yamamoto, Hironori, Taketani, Yutaka, Doi, Toshio, Takeda, Eiji
Format: Artigo
Język:Inglês
Wydane: the Society for Free Radical Research Japan 2007
Hasła przedmiotowe:
Original Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2275770/
https://ncbi.nlm.nih.gov/pubmed/18398502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3164/jcbn.40.234
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy